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First Case of Tularemia Reported in
Portugal: Probably of Imported Origin
Isabel Lopes de Carvalho 1*, Paula Nascimento 2, Maria Sofia Núncio 1 and
Miguel Toscano Rico 2
1 Infectious Department, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal, 2 Internal Medicine Service 4, Centro
Hospitalar de Lisboa Central, Santa Marta Hospital, Lisbon, Portugal
The authors report the case of a 47-year-old man who walked in the countryside on
the island of Bornholm, during the summer period. Three days later, fever, myalgias
and adynamia began. The serological tests, Real-time PCR and isolation of the bacteria
from the culture of lymph biopsy confirmed the presence of Francisella tularensis subsp.
holarctica.
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INTRODUCTION
Tularemia is a zoonotic disease caused by Francisella tularensis, a gram-negative, facultative
intracellular bacterium. Typically, human and animal infections are caused by F. tularensis
subspecies tularensis (type A) strains mainly in Canada and USA, and F. tularensis subspecies
holarctica (type B) strains throughout the northern hemisphere, including Europe (1, 2).
Tularemia is a disease with epidemiological surveillance in Europe since 2003
(Decision 2000/96/EC) (3). Despite being considered an uncommon disease, recent outbreaks have
been reported in several countries, including Spain, France, Scandinavia, Balkans and Hungary,
and sporadic cases in Austria, Italy and the United Kingdom (4).
In spite offbeing a disease of compulsory declaration in Portugal since 2003, until now no human
cases were reported.
In Portugal, seroprevalence rate of high-risk population is 8.9% (5) and F. tularensis subsp.
holarctica was first detected in 2007 by molecular methods in a human sample (6). Since 1998,
National Institute of Health has provided the laboratory diagnosis of this disease, following the
occurrence of an epidemic outbreak in Spain.
The authors report here the first case of ulceroglandular form of tularemia in Portugal, probably
of imported origin.
CASE REPORT
This study was carried out in accordance with the recommendations of the guidelines of Helsinki
Committee. A written informed consent was obtained from the patient for publication of this case
report.
A previously healthy 47-years-old male developed abruptly malaise, high fever (40◦C) and chills
only 3 days after walking and sleeping in the countryside of the island of Bornholm (Denmark)
during summer season. He also reported profuse night sweats, a small left infraclavicular
non-painful cutaneous lesion. The patient did not report outdoor activities in the month before
and did not recall any tick bite. Three days later the fever vanished and he was first observed in a
hospital in Berlin. He was prescribed with amoxicillin/clavulanate 875mg/125mg twice-a-day for 7
days.
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On the 15th day of disease, he was observed in Portugal
because of ongoing malaise. During the observation he did not
complain of respiratory symptoms nor headache..
He presented a non-pruritic macular erythematous rash of the
trunk, a non-painful left infraclavicular cutaneous lesion covered
with a black crust suggestive of a skin eschar and multiple small
painless, non-adherent cervical, and axillar lymphadenopathies
(Figures 1, 2).
Routine laboratory tests evidenced minor unspecific
inflammatory abnormalities: white blood count (WBC;
leucocytes 12.060 × 106/L, polymorphonuclear predominancy),
platelet count 307000 × 106/L, C-reactive protein 28.4
mg/L. Liver functions tests, blood urea nitrogen, creatinine
and electrolyte levels, were within normal range. Human
immunodeficiency virus infection tested negative.
Soft tissue ultrasound revealed several lymphadenopathies of
the left axillary region, most within dimensions of 1.0–1.5cm (of
the largest axis) and two larger (1.8 and 2.3cm) with tendency to
suppuration.
Considering an exanthematic fever and an inoculation-like
lesion, a Rickettsial infection or Lyme borreliosis were suspected.
Blood samples were collected and the patient initiated empirically
doxycycline 100mg bid (twice a day). Later on both detections
for antibodies to Rickettsia sp. and Borrelia burgdorferi s.l
were negative. Careful revision of zoonosis with prominent
lymphadenopathies in Denmark was carried out and an infection
with Francisella tularensis was suspected.
Serum specimen was shown to be positive for F. tularensis
specific antibodies, which was demonstrated by an agglutination
test with a titer of 160 (7), followed by enzyme-linked
immunosorbent assay (ELISA) classic Francisella tularensis
(Virion/Serion GmbH Institute,Würzburg, Germany) IgM (titer:
114.53 U/ml (cut-off 15 U/ml), and IgG (titer: > 300 U/ml (cut
off 15 U/ml).
As the patient showed no improvement after 4 days with
doxicycline he started intramuscular streptomycin 1 g every 12 h
in an outpatient basis for 10 days without complications.
The inoculation-like lesion resolved, but the
lymphadenopathies remained mostly unchanged. Despite
this, the patient left Portugal for working reasons.
Three weeks later the left cervical lymphadenopathy increased
in size and the axillary evolved into a suppurative lymphadenitis.
He was called back and an excision of the left cervical lymph node
was performed.
The excisional biopsy of the lymph node was cultured on
chocolate agar media (bioMérieux) at 37◦C in a 5% CO2-
enriched atmosphere of (8). After 3 days, some suspicious
colonies of Francisella grow. This observation was confirmed
by a real-time multitarget TaqMan PCR, using tul4 and ISFtu2
assays (9) and fopA gene (10) with positives further tested using
real-time TaqMan PCR assays which differentiate between F.
tularensis subsp. tularensis (type A) and F. tularensis subsp.
holarctica (type B) (11). For additional characterization, a
phylogenetically informative region of lpnA (231 bp) was
amplified by conventional PCR as previous described (12).
Amplicons obtained by lpnA PCR were purified and
sequenced with the ABI BigDye Terminator Cycle Sequencing
FIGURE 1 | Eschar of inoculation and Rash taken on the 15th day.
FIGURE 2 | Left cervical adenopathy taken on the 15th day.
Ready Reaction Kit (Applied Biosystems, Inc., Foster City, CA,
USA). The lpnA sequences for F. tularensis subsp. holarctica
(PoHuF2) was assigned with the GenBank accession number:
MH068785.
On the other hand, histopathology showed cell necrosis and
no evidence of tumor cells nor Mycobacterium tuberculosis
bacilli was found. An ulceroglandular form of tularemia was
unequivocally diagnosed.
In the absence of response to the first line antibiotic therapy
with aminoglycosides, he was treated with ciprofloxacin 500mg
twice-a-day for 60 days and performed percutaneous drainage of
the bigger axillar lymph nodes with clinical improvement.
DISCUSSION
Clinical presentation of tularemia is poorly specific and
clinical signs vary according with its six main clinical
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presentation forms: ulceroglandular, glandular, oculoglandular,
oropharyngeal, pneumonic and typhoidal (1, 13, 14).
Our patient presented with a typical ulceroglandular form
and as frequently described, he developed a suppurative
lymphadenitis, requiring surgical drainage and lymph node
resection.
The European Center for Disease Control and Prevention
(ECDC) 2016 surveillance report refers 526 confirmed cases in a
number of European countries in 2014, with Sweden reporting
the highest case rate (3). Although there are no reports of
tularemia for Denmark in 2003 a confirmed case of human was
recorded (15). Furthermore in 2001, two cases of tularemia were
reported after an orienteering contest on the Island of Bornholm,
at the same location where we consider the transmission of
infection occurred for the present case (16). The case here
presented highlights the role of ticks as vectors in transmission
of tularemia, since the patient showed an eschar of inoculation.
Moreover, commonly the infection occurs during warm seasons
in adult men. Ulcer and lymphadenopathies are reported in the
upper and lower parts of the body when infections are caused by
arthropods, as happen in the present case (1).
Tularemia is often a prolonged and debilitating disease.
Three cases of tick-borne transmission between 2012 and 2013
have been reported in Germany (17), data from France point
out that more than 10% of reported human infections of F.
tularensis is derived by tick transmission (13). In Switzerland,
three probable cases of tick-borne tularemia were described
in 2013 (17). In Portugal until now no human cases were
reported despite the detection of F. tularensis subsp. holarctica
in different tick species, lagomorphs and in one human sample
(6, 18). In humans tularemia probably represents a re-emerging
disease with a high proportion of undiagnosed cases (19). Our
report represents the first imported tularemia case notified in
Portugal.
Despite aminoglycosides remains the treatment of choice
for severe forms, fluoroquinolones and doxycycline may be
appropriate for the less severe ones. Failures in empirical
therapy are described, but mostly occur because of the delay in
treatment with the appropriate antibiotic. Some reports suggest
that fluoroquinolones are associated with lower relapse rates,
particularly in patients with extensive lymph node involvement,
for which a 2–3 week treatment course is usually insufficient for
cure (1, 14).
Delay in initiating appropriate treatment (around 2 weeks)
and extensive lymphadenopathy involvement might have
contributed to streptomycin failure and should have favored a
quinolone-basis treatment instead. We decided for a 2-months
ciprofloxacin treatment due to the persistence of documented
viable bacteria in cervical ganglion and markers of cure are not
available so far.
To our best knowledge, this was the first notified case of
tularemia in Portugal of highly probable imported origin. The
increasing mobility of travelers and the potential for exposure
to diseases outside their home countries poses clinicians an
increased effort to know the epidemiological background of the
patients.
The present case illustrates the importance to include
tularemia in the differential diagnosis of patients with fever
combined with a lymphadenopathy (ulcerative or not) and to
initiate early laboratory diagnosis of suspicious cases. Moreover,
good communication between clinicians and the reference
laboratory was important to achieve the diagnosis of this
patient.
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